New Delhi, Sept. 21 -- The laboratories of the Council of Scientific and Industrial Research (CSIR), National Botanical Research Institute (NBRI), Central Institute of Medicinal and Aromatic Plants (CIMAP), Indian Institute of Toxicology Research (IITR), and Central Drug Research Institute (CDRI) collaborate to develop drugs for diabetes, blood cancer, fatty liver, and liver cell degeneration.

India's herbal healthcare sector is preparing for a new growth phase, as traditional medicine blends with modern science to produce validated, affordable, and globally competitive solutions. This momentum was on full display at the recently concluded two-day CSIR Startup Conclave, where research institutions, startups, and policymakers joined force...